{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:50:18Z","timestamp":1782291018032,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,24]]},"group-title":"In Review","reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS105979"],"award-info":[{"award-number":["R01 NS105979"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Parkinson\u2019s disease (PD) is associated with substantial placebo effects. We used network analysis to identify a specific sham surgery-related pattern (SSRP) in metabolic PET data from a double-blind PD gene therapy trial. Baseline SSRP expression measured before randomization correlated with motor improvement under the blind after sham surgery. To validate this predictive relationship, we measured baseline SSRP levels in two independent placebo-controlled trials of pharmacologic PD treatments administered orally or by subcutaneous injection. As with sham surgery, pre-randomization SSRP expression correlated with placebo responses in each of the validation groups. Using magnetic resonance diffusion tensor imaging (DTI), we found that individual differences in SSRP expression and placebo response were attributable to variation in the density of fiber tracts linking key network nodes, particularly the nucleus accumbens and the anterior cingulate cortex. The findings support SSRP as a network-based imaging marker of placebo susceptibility in PD clinical trials.\n                  <bold>Teaser<\/bold>\n                  : Placebo responses in Parkinson\u2019s disease clinical trials are predicted by baseline expression of a specific brain network.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10119103\/v1","type":"posted-content","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:35:26Z","timestamp":1782290126000},"source":"Crossref","is-referenced-by-count":0,"title":["Parkinson\u2019s disease: Individual placebo responses are predicted by baseline expression of a striato-limbic network"],"prefix":"10.21203","author":[{"given":"J\u00e1nos","family":"Barbero","sequence":"first","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Vo","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Strohl","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Vacca","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris C.","family":"Tang","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nha","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashin","family":"Unadkat","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Ma","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichun","family":"Peng","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Niethammer","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brage","family":"Brakedal","sequence":"additional","affiliation":[{"name":"Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Wallin","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Markaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Kaplitt","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Tzoulis","sequence":"additional","affiliation":[{"name":"Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eidelberg","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/brain\/awn116","article-title":"Oken, Placebo effects: Clinical aspects and neurobiology","volume":"131","year":"2008","unstructured":"B. S. Oken, Placebo effects: Clinical aspects and neurobiology. Brain. 131, 2812\u20132823 (2008)","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson\u2019s disease: Comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"Goetz CG","year":"2008","unstructured":"Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Kieburtz K, Leurgans S (2008) Placebo response in Parkinson\u2019s disease: Comparisons among 11 trials covering medical and surgical interventions. Mov Disord 23:690\u2013699","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.25387","article-title":"Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation","volume":"85","author":"Burke MJ","year":"2019","unstructured":"Burke MJ, Kaptchuk TJ, Pascual-Leone A (2019) Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation. Ann Neurol 85:12\u201320","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.irn.2020.03.031","article-title":"Placebo responses in Parkinson\u2019s disease","volume":"153","author":"Lou JS","year":"2020","unstructured":"Lou JS (2020) Placebo responses in Parkinson\u2019s disease. Int Rev Neurobiol 153:187\u2013211","journal-title":"Int Rev Neurobiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ncl.2025.08.003","article-title":"Placebo Responses in Trials of Parkinson\u2019s Disease","volume":"44","author":"Garg S","year":"2026","unstructured":"Garg S, Mestre T (2026) Placebo Responses in Trials of Parkinson\u2019s Disease. Neurol Clin 44:47\u201361","journal-title":"Neurol Clin"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone SC","year":"2010","unstructured":"Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, De La Fuente-Fern\u00e1ndez R, Phillips AG, Stoessl AJ (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67:857\u2013865","journal-title":"Arch Gen Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1113\/JP271322","article-title":"Teaching neurons to respond to placebos","volume":"594","author":"Benedetti F","year":"2016","unstructured":"Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, Zibetti M, Lanotte M, Lopiano L (2016) Teaching neurons to respond to placebos. J Physiol 594:5647\u20135660","journal-title":"J Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mds.27438","article-title":"Neurobiology of placebo effect in Parkinson\u2019s disease: What we have learned and where we are going","volume":"33","author":"Quattrone A","year":"2018","unstructured":"Quattrone A, Barbagallo G, Cerasa A, Stoessl AJ (2018) Neurobiology of placebo effect in Parkinson\u2019s disease: What we have learned and where we are going. Mov Disord 33:1213\u20131227","journal-title":"Mov Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1172\/JCI75073","article-title":"Network modulation following sham surgery in Parkinson\u2019s disease","volume":"124","author":"Ko JH","year":"2014","unstructured":"Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, Dhawan V, During MJ, Kaplitt MG, Eidelberg D (2014) Network modulation following sham surgery in Parkinson\u2019s disease. J Clin Invest 124:3656\u20133666","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"eaau0713","DOI":"10.1126\/scitranslmed.aau0713","article-title":"Gene therapy reduces Parkinson\u2019s disease symptoms by reorganizing functional brain connectivity","volume":"10","author":"Niethammer M","year":"2018","unstructured":"Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ, Kaplitt MG, Eidelberg D (2018) Gene therapy reduces Parkinson\u2019s disease symptoms by reorganizing functional brain connectivity. Sci Transl Med 10:eaau0713","journal-title":"Sci Transl Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1474-4422(25)00125-5","article-title":"Gene therapy for Parkinson\u2019s disease: trials and technical advances","volume":"24","author":"Winston G","year":"2025","unstructured":"Winston G, Kharas N, Svenningsson P, Jha A, Kaplitt MG (2025) Gene therapy for Parkinson\u2019s disease: trials and technical advances. Lancet Neurol 24:548\u2013556","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-022-00753-3","article-title":"Functional brain networks in the evaluation of patients with neurodegenerative disorders","volume":"19","author":"Perovnik M","year":"2023","unstructured":"Perovnik M, Rus T, Schindlbeck KA, Eidelberg D (2023) Functional brain networks in the evaluation of patients with neurodegenerative disorders. Nat Rev Neurol 19:73\u201390","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e00699","DOI":"10.1016\/j.neurot.2025.e00699","article-title":"Preoperative network activity predicts the response to subthalamic DBS for Parkinson\u2019s disease","volume":"22","author":"Unadkat P","year":"2025","unstructured":"Unadkat P, Vo A, Ma Y, Tang CC, Dhawan V, Niethammer M, Nguyen N, Peng S, Mishra A, Ramdhani R, Fenoy A, Caminiti SP, Perani D, Eidelberg D (2025) Preoperative network activity predicts the response to subthalamic DBS for Parkinson\u2019s disease. Neurotherapeutics 22:e00699","journal-title":"Neurotherapeutics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2015.02.009","article-title":"Genetics and the placebo effect: The placebome","volume":"21","author":"Hall KT","year":"2015","unstructured":"Hall KT, Loscalzo J, Kaptchuk TJ (2015) Genetics and the placebo effect: The placebome. Trends Mol Med 21:285\u2013294","journal-title":"Trends Mol Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal B","year":"2022","unstructured":"Brakedal B, D\u00f6lle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlm\u00fcller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Gr\u00fcner R, Eidelberg D, Tzoulis C (2022) The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab 34:396\u2013407e6","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt PA","year":"2011","unstructured":"LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A (2011) AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10:309\u2013319","journal-title":"Lancet Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e90133","DOI":"10.1172\/jci.insight.90133","article-title":"Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson\u2019s disease","volume":"2","author":"Niethammer M","year":"2017","unstructured":"Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ, Kaplitt MG, Feigin A (2017) Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson\u2019s disease. JCI Insight 2:e90133","journal-title":"JCI Insight"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/comnet\/cnv005","article-title":"Assortativity in complex networks","volume":"3","author":"Noldus R","year":"2015","unstructured":"Noldus R, Van Mieghem P (2015) Assortativity in complex networks. J Complex Networks 3:507\u2013542","journal-title":"J Complex Networks"},{"key":"ref19","volume-title":"Network Science","author":"Barabasi A-L","year":"2016","unstructured":"Barabasi A-L (2016) Network Science. Cambridge Univeristy, Cambridge, UK"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s41109-017-0025-4","article-title":"Robustness and efficiency in interconnected networks with changes in network assortativity","volume":"2","author":"Murakami M","year":"2017","unstructured":"Murakami M, Ishikura S, Kominami D, Shimokawa T, Murata M (2017) Robustness and efficiency in interconnected networks with changes in network assortativity. Appl Netw Sci 2:6","journal-title":"Appl Netw Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/cercor\/bhac110","article-title":"Adaptive and pathological connectivity responses in Parkinson\u2019s disease brain networks","volume":"33","author":"Vo A","year":"2023","unstructured":"Vo A, Schindlbeck KA, Nguyen N, Rommal A, Spetsieris PG, Tang CC, Choi YY, Niethammer M, Dhawan V, Eidelberg D (2023) Adaptive and pathological connectivity responses in Parkinson\u2019s disease brain networks. Cereb Cortex 33:917\u2013932","journal-title":"Cereb Cortex"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"066103","DOI":"10.1103\/PhysRevE.86.066103","article-title":"Assortativity decreases the robustness of interdependent networks","volume":"86","author":"Zhou D","year":"2012","unstructured":"Zhou D, Stanley HE, D\u2019Agostino G, Scala A (2012) Assortativity decreases the robustness of interdependent networks. Phys Rev E - Stat Nonlinear Soft Matter Phys 86:066103","journal-title":"Phys Rev E - Stat Nonlinear Soft Matter Phys"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0157868","DOI":"10.1371\/journal.pone.0157868","article-title":"Analysis of the effect of degree correlation on the size of minimum dominating sets in complex networks","volume":"11","author":"Takemoto K","year":"2016","unstructured":"Takemoto K, Akutsu T (2016) Analysis of the effect of degree correlation on the size of minimum dominating sets in complex networks. PLoS ONE 11:e0157868","journal-title":"PLoS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41467-017-02681-z","article-title":"Diversity of meso-scale architecture in human and non-human connectomes","volume":"9","author":"Betzel RF","year":"2018","unstructured":"Betzel RF, Medaglia JD, Bassett DS (2018) Diversity of meso-scale architecture in human and non-human connectomes. Nat Commun 9:346","journal-title":"Nat Commun"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1101\/355016","article-title":"Non-assortative community structure in resting and task-evoked functional brain networks","author":"Betzel RF","year":"2018","unstructured":"Betzel RF, Bertolero MA, Bassett DS (2018) Non-assortative community structure in resting and task-evoked functional brain networks. https:\/\/doi.org\/10.1101\/355016. bioRxiv"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41467-017-01189-w","article-title":"The diverse club","volume":"8","author":"Bertolero MA","year":"2017","unstructured":"Bertolero MA, Yeo BTT, D\u2019Esposito M (2017) The diverse club. Nat Commun 8:1277","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/pr.115.010512","article-title":"Dopamine\u2019s actions in primate prefrontal cortex: Challenges for treating cognitive disorders","volume":"67","author":"Arnsten AFT","year":"2015","unstructured":"Arnsten AFT, Wang M, Paspalas CD (2015) Dopamine\u2019s actions in primate prefrontal cortex: Challenges for treating cognitive disorders. Pharmacol Rev 67:681\u2013696","journal-title":"Pharmacol Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1162\/netn_a_00042","article-title":"Catecholaminergic manipulation alters dynamic network topology across cognitive states","volume":"2","author":"Shine JM","year":"2018","unstructured":"Shine JM, van den Brink RL, Hernaus D, Nieuwenhuis S, Poldrack RA (2018) Catecholaminergic manipulation alters dynamic network topology across cognitive states. Netw Neurosci 2:381\u2013396","journal-title":"Netw Neurosci"},{"key":"ref29","author":"Spetsieris PG","year":"2015","unstructured":"Spetsieris PG, Ko JH, Tang CC, Nazem A, Sako W, Peng S, Ma Y, Dhawan V, Eidelberg D (2015) Metabolic resting-state brain networks in health and disease. Proc. Natl. Acad. Sci. U. S. A. 112, 2563\u20132568"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-clinpsy-021815-093015","article-title":"Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account","volume":"13","author":"Ashar YK","year":"2017","unstructured":"Ashar YK, Chang LJ, Wager TD (2017) Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account. Annu Rev Clin Psychol 13:73\u201389","journal-title":"Annu Rev Clin Psychol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1093\/cercor\/bhy188","article-title":"The Functional Role of Large-scale Brain Network Coordination in Placebo-induced Anxiolysis","volume":"29","author":"Meyer B","year":"2019","unstructured":"Meyer B, Yuen KSL, Saase V, Kalisch R (2019) The Functional Role of Large-scale Brain Network Coordination in Placebo-induced Anxiolysis. Cereb Cortex 29:3201\u20133210","journal-title":"Cereb Cortex"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/mds.27142","article-title":"The placebo effect on bradykinesia in Parkinson\u2019s disease with and without prior drug conditioning","volume":"32","author":"Frisaldi E","year":"2017","unstructured":"Frisaldi E, Carlino E, Zibetti M, Barbiani D, Dematteis F, Lanotte M, Lopiano L, Benedetti F (2017) The placebo effect on bradykinesia in Parkinson\u2019s disease with and without prior drug conditioning. Mov Disord 32:1474\u20131478","journal-title":"Mov Disord"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1038\/s41467-024-54695-z","article-title":"Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder","volume":"15","author":"Tang CC","year":"2024","unstructured":"Tang CC, Nakano Y, Vo A, Nguyen N, Schindlbeck KA, Mattis PJ, Poston KL, Gagnon J-F, Postuma RB, Niethammer M, Ma Y, Peng S, Dhawan V, Eidelberg D (2024) Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder. Nat Commun 15:10797","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuron.2023.10.020","article-title":"A stress-sensitive frontostriatal circuit supporting effortful reward-seeking behavior","volume":"112","author":"Fetcho RN","year":"2024","unstructured":"Fetcho RN, Parekh PK, Chou J, Kenwood M, Chalen\u00e7on L, Estrin DJ, Johnson M, Liston C (2024) A stress-sensitive frontostriatal circuit supporting effortful reward-seeking behavior. Neuron 112:473\u2013487e4","journal-title":"Neuron"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41467-021-21179-3","article-title":"Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data","volume":"12","author":"Zunhammer M","year":"2021","unstructured":"Zunhammer M, Spis\u00e1k T, Wager TD, Bingel U, Atlas L, Benedetti F, B\u00fcchel C, Choi JC, Colloca L, Duzzi D, Eippert F, Ellingsen DM, Elsenbruch S, Geuter S, Kaptchuk TJ, Kessner SS, Kirsch I, Kong J, Lamm C, Leknes S, Lui F, M\u00fcllner-Huber A, Porro CA, R\u00fctgen M, Schenk LA, Schmid J, Theysohn N, Tracey I, Wrobel N, Zeidan F (2021) Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data. Nat Commun 12:1391","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41586-024-07816-z","article-title":"Neural circuit basis of placebo pain relief","volume":"632","author":"Chen C","year":"2024","unstructured":"Chen C, Niehaus JK, Dinc F, Huang KL, Barnette AL, Tassou A, Shuster SA, Wang L, Lemire A, Menon V, Ritola K, Hantman AW, Zeng H, Schnitzer MJ, Scherrer G (2024) Neural circuit basis of placebo pain relief. Nature 632:1092\u20131100","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ijnp\/pyac009","article-title":"Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review","volume":"25","author":"Huneke NTM","year":"2022","unstructured":"Huneke NTM, Aslan IH, Fagan H, Phillips N, Tanna R, Cortese S, Garner M, Baldwin DS (2022) Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review. Int J Neuropsychopharmacol 25:433\u2013447","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM199909233411312","article-title":"The Ethical Problems with Sham Surgery in Clinical Research","volume":"341","author":"Macklin R","year":"1999","unstructured":"Macklin R (1999) The Ethical Problems with Sham Surgery in Clinical Research. N Engl J Med 341:992\u2013996","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JPD-191577","article-title":"Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson\u2019s Disease","volume":"9","author":"Polgar S","year":"2019","unstructured":"Polgar S, Mohamed S (2019) Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson\u2019s Disease. J Parkinsons Dis 9:565\u2013574","journal-title":"J Parkinsons Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"641","author":"Tabar V","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, Brennan C, Ma Y, Peng S, Eidelberg D, Tomishima M, Irion S, Stemple W, Abid N, Lampron A, Studer L, Henchcliffe C (2025) Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature 641:978\u2013983","journal-title":"Nature"},{"issue":"1","key":"ref41","article-title":"Effect of Exenatide on disease progression in early Parkinson\u2019s disease\u2013a randomized, placebo controlled, single-center trial in Sweden [abstract]","volume":"40","author":"Markaki I","year":"2025","unstructured":"Markaki I, Tang CC, Papathoma PE, Hainke L, Paslawski W, Paslawska J, Savitcheva I, Estenberg U, Eidelberg D, Svenningsson P (2025) Effect of Exenatide on disease progression in early Parkinson\u2019s disease\u2013a randomized, placebo controlled, single-center trial in Sweden [abstract]. Mov Disord 40, Suppl 1","journal-title":"Mov Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/jphysiol.2009.169425","article-title":"Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response","volume":"587","author":"Benedetti F","year":"2009","unstructured":"Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L (2009) Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol 587:3869\u20133883","journal-title":"J Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hbm.23907","article-title":"Disruption of network for visual perception of natural motion in primary dystonia","volume":"39","author":"Fujita K","year":"2018","unstructured":"Fujita K, Sako W, Vo A, Bressman SB, Eidelberg D (2018) Disruption of network for visual perception of natural motion in primary dystonia. Hum Brain Mapp 39:1163\u20131174","journal-title":"Hum Brain Mapp"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1093\/cercor\/bhab148","article-title":"Cognition-Related Functional Topographies in Parkinson\u2019s Disease: Localized Loss of the Ventral Default Mode Network","volume":"31","author":"Schindlbeck KA","year":"2021","unstructured":"Schindlbeck KA, Vo A, Mattis PJ, Villringer K, Marzinzik F, Fiebach JB, Eidelberg D (2021) Cognition-Related Functional Topographies in Parkinson\u2019s Disease: Localized Loss of the Ventral Default Mode Network. Cereb Cortex 31:5139\u20135150","journal-title":"Cereb Cortex"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3758\/s13415-022-01039-3","article-title":"Targeting neural correlates of placebo effects","volume":"23","author":"Romanella SM","year":"2023","unstructured":"Romanella SM, Mencarelli L, Burke MJ, Rossi S, Kaptchuk TJ, Santarnecchi E (2023) Targeting neural correlates of placebo effects. Cogn Affect Behav Neurosci 23:217\u2013236","journal-title":"Cogn Affect Behav Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","article-title":"Automated anatomical labelling atlas 3","volume":"206","author":"Rolls ET","year":"2020","unstructured":"Rolls ET, Huang CC, Lin CP, Feng J, Joliot M (2020) Automated anatomical labelling atlas 3. NeuroImage 206:116189","journal-title":"NeuroImage"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhz280","article-title":"LRRK2 and GBA Variants Exert Distinct Influences on Parkinson\u2019s Disease-Specific Metabolic Networks","volume":"30","author":"Schindlbeck KA","year":"2020","unstructured":"Schindlbeck KA, Vo A, Nguyen N, Tang CC, Niethammer M, Dhawan V, Brandt V, Saunders-Pullman R, Bressman SB, Eidelberg D (2020) LRRK2 and GBA Variants Exert Distinct Influences on Parkinson\u2019s Disease-Specific Metabolic Networks. Cereb Cortex 30:2867\u20132878","journal-title":"Cereb Cortex"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199206650.001.0001","volume-title":"Networks: An Introduction","author":"Newman MEJ","year":"2010","unstructured":"Newman MEJ (2010) Networks: An Introduction. Oxford University Press, Oxford, UK"},{"key":"ref49","author":"Peel L","year":"2018","unstructured":"Peel L, Delvenne JC, Lambiotte R (2018) Multiscale mixing patterns in networks. Proc. Natl. Acad. Sci. U. S. A. 115, 4057\u20134062"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: Uses and interpretations","volume":"52","author":"Rubinov M","year":"2010","unstructured":"Rubinov M, Sporns O (2010) Complex network measures of brain connectivity: Uses and interpretations. NeuroImage 52:1059\u20131069","journal-title":"NeuroImage"},{"key":"ref51","first-page":"499","volume":"23","author":"Bassett DS","year":"2017","unstructured":"Bassett DS, Bullmore ET (2017) Small-World Brain Networks Revisit Neuroscientist 23:499\u2013516","journal-title":"Small-World Brain Networks Revisit Neuroscientist"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson M","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825\u2013841","journal-title":"NeuroImage"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1109\/TMI.2010.2045126","article-title":"Generalized q-sampling imaging","volume":"29","author":"Yeh FC","year":"2010","unstructured":"Yeh FC, Wedeen VJ, Tseng WYI (2010) Generalized q-sampling imaging. IEEE Trans Med Imaging 29:1626\u20131635","journal-title":"IEEE Trans Med Imaging"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e80713","DOI":"10.1371\/journal.pone.0080713","article-title":"Y. I. Tseng, Deterministic diffusion fiber tracking improved by quantitative anisotropy","volume":"8","author":"Yeh FC","year":"2013","unstructured":"Yeh FC, Verstynen TD, Wang Y, Fern\u00e1ndez-Miranda JC (2013) Y. I. Tseng, Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS ONE 8:e80713","journal-title":"PLoS ONE"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"117329","DOI":"10.1016\/j.neuroimage.2020.117329","article-title":"Shape analysis of the human association pathways","volume":"223","author":"Yeh FC","year":"2020","unstructured":"Yeh FC (2020) Shape analysis of the human association pathways. NeuroImage 223:117329","journal-title":"NeuroImage"},{"key":"ref56","author":"Goetz CG","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Agarwal P, Athar S, Bordelan Y, Bronte-Stewart HM, Camicioli R, Chou K, Cole W, Dalvi A, Delgado H, Diamond A, Dick JP, Duda J, Elble RJ, Evans C, Evidente VG, Fernandez HH, Fox S, Friedman JH, Fross RD, Gallagher D, Goetz CG, Hall D, Hermanowicz N, Hinson V, Horn S, Hurtig H, Kang UJ, Kleiner-Fisman G, Klepitskaya O, Kompoliti K, Lai EC, Leehey ML, Leroi I, Lyons KE, McClain T, Metzer SW, Miyasaki J, Morgan JC, Nance M, Nemeth J, Pahwa R, Parashos SA, Schneider JS, Sethi K, Shulman LM, Siderowf A, Silverdale M, Simuni T, Stacy M, Stern MB, Stewart RM, Sullivan K, Swope DM, Wadia PM, Walker RW, Walker R, Weiner WJ, Wiener J, Wilkinson J, Wojcieszek JM, Wolfrath S, Wooten F, Wu A, Zesiewicz TA, Zweig RM (2008) Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1452741","DOI":"10.3389\/fneur.2024.1452741","article-title":"Rate of motor progression in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Pauwels A","year":"2024","unstructured":"Pauwels A, Phan ALG, Ding C, Phan TG, Kempster PA (2024) Rate of motor progression in Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 15:1452741","journal-title":"Front Neurol"},{"key":"ref58","volume-title":"Exploratory Data Analysis","author":"Tukey JW","year":"1977","unstructured":"Tukey JW (1977) Exploratory Data Analysis. Addison-Wesley Publishing Company"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/mds.26435","article-title":"Simplified conversion method for unified Parkinson\u2019s disease rating scale motor examinations","volume":"30","author":"Hentz JG","year":"2015","unstructured":"Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH (2015) Simplified conversion method for unified Parkinson\u2019s disease rating scale motor examinations. Mov Disord 30:1967\u20131970","journal-title":"Mov Disord"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119103\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119103\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:35:33Z","timestamp":1782290133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119103\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":59,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10119103\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,6,24]]},"subtype":"preprint"}}